In this episode of the Beasley Allen Report, Beasley Allen attorney Matt Teague is invited to discuss a developing line of drugs used to treat low testosterone, a condition also known as “Low-T.” Although the short-term benefits of these drugs quickly become apparent to the user, new studies have confirmed that the long-term effects of the drugs range from blood clots, stroke, heart attack and even death.
Teague describes Low-T as a condition that was created and marketed toward men who sought medical advice for erectile dysfunction. Doctors tell these consumers that natural aging processes such as weight gain, diminished libido and lack of energy can be attributed to Low-T and can be treated using drugs like AndroGel and Testim. According to a study published in the Journal of the American Medical Association (JAMA) in November 2013, older men who used testosterone supplements such as these for three years were as much as 30 percent more likely to have a heart attack, stroke or die from any cause compared to similar-aged men who did not use the supplements.
Teague joined the firm in 2011, focusing his practice on dangerous and defective pharmaceutical drugs and medical devices. As a graduate of Cumberland School of Law, Teague has served two terms as an elected member of the Birmingham Bar Association’s Young Lawyers Executive Committee, and is a member of the Montgomery County Association for Justice. Teague has also served as a volunteer committee member for several Cystic Fibrosis Foundation fundraising events and is an active member of the Jimmy Hitchcock Award Committee.